Screener
RenovoRx RNXT Q4 2025 Annual earnings
Reported March 30, 2026 · After market close
Revenue$238.0KMiss by $181.7K
EPS-$0.08In line
Revenue estimate$419.7K
EPS estimate-$0.08
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$952.0K
EPS estimate-$0.05
Versus estimates
Revenue
Diluted EPS
FAQ
- When did RenovoRx report Q4 2025 earnings?
- RenovoRx (RNXT) reported Q4 2025 earnings on March 30, 2026 after market close.
- What were RenovoRx's Q4 2025 revenue and EPS?
- RenovoRx reported revenue of $238.0K and eps of $-0.08 for Q4 2025.
- Did RenovoRx beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $419.7K by $181.7K. EPS beat the consensus estimate of $-0.08 by $0.00.
- How did RenovoRx's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 453.5% from $43.0K a year earlier and eps grew 33.3% from $-0.12.
- Where can I find RenovoRx's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001493152-26-013080) and the 10-K periodic report (0001193125-26-131928) directly on SEC EDGAR. The filing index links above go to sec.gov.
